Thrombolytic therapy in patients with submassive pulmonary embolism.
Ajani
Andrew E
AE
Waksman
Ron
R
D004359:Drug Therapy, Combination; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D006976:Hypertension, Pulmonary / Q000150:complications; D011655:Pulmonary Embolism / Q000145:classification / Q000150:complications / Q000188:drug therapy*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D018497:Ventricular Dysfunction, Right / Q000150:complications
D005343:Fibrinolytic Agents; D006493:Heparin; D010959:Tissue Plasminogen Activator